Botox Vs. Dysport for Wrinkles
Understanding the Difference
If you are considering injectable wrinkle treatment, you have likely come across two of the most popular options: Botox and Dysport. Both are FDA-approved neuromodulators that temporarily relax facial muscles to smooth fine lines and wrinkles, but they differ in formulation, onset, and how they spread beneath the skin. Botox (onabotulinumtoxinA) is produced by Allergan, while Dysport (abobotulinumtoxinA) is manufactured by Galderma. Although both use botulinum toxin type A as their active ingredient, the purification process, protein complexing, and molecular weight differ between the two products. These formulation differences influence how each product behaves once injected, including how far it spreads from the injection site and how quickly it takes effect. According to the ASPS 2024 Report, neuromodulator injections reached nearly 9.9 million treatments in the United States in 2024.
Both Botox and Dysport are FDA-approved for treating moderate to severe glabellar lines, the vertical frown lines between the eyebrows. Botox has additional FDA approvals for crow's feet and horizontal forehead lines. In clinical practice, both products are widely used off-label for a variety of facial areas, and our oculoplastic surgeon selects the product best suited to each patient's anatomy and treatment goals.
Both products block the release of acetylcholine, a neurotransmitter that signals muscles to contract. By temporarily reducing muscle activity in targeted areas, wrinkles caused by repeated facial expressions gradually soften. The underlying mechanism is the same for both Botox and Dysport, but differences in diffusion and potency per unit mean that each product requires its own dosing and injection technique. You can learn more about the fundamentals of Botox treatment and how neuromodulators work overall.
Onset and Speed of Results
Speed of onset is one of the most commonly discussed differences between Botox and Dysport. Dysport generally begins to show visible results within two to three days after injection. Botox typically takes three to five days before patients notice initial smoothing, with full results developing over one to two weeks for both products. While the difference in onset is relatively small, patients who want faster visible improvement sometimes prefer Dysport for that reason.
The faster onset of Dysport is thought to be related to its smaller protein complex size, which may allow it to bind to nerve receptors more quickly after injection. This molecular difference does not affect the final outcome or duration of results, but it can be a deciding factor for patients preparing for an upcoming event or occasion.
Regardless of which product you choose, the full effect of treatment typically becomes apparent within 10 to 14 days. We recommend scheduling a follow-up appointment about two weeks after your injection so we can assess your results and make any refinements if needed.
Diffusion and Spread Patterns
The way a neuromodulator diffuses from the injection site affects both the results and the precision of treatment, making this an important consideration when comparing the two products. Dysport has a greater tendency to spread from the injection point compared to Botox. This broader diffusion pattern means Dysport can cover a wider area with fewer injection points, which can be advantageous for treating larger zones like the forehead. Botox tends to stay more localized, giving the injector precise control over smaller, targeted areas.
For broad areas of muscle activity, Dysport's natural diffusion can create a smooth, even result with potentially fewer injection sites. Patients who want a natural, relaxed appearance across a wide treatment zone may benefit from Dysport's spreading properties. Treating the periorbital area with neuromodulators requires careful technique regardless of which product is used, since the muscles around the eyes are delicate and closely spaced.
In areas where precision is critical, such as around the brow or near the eyelids, Botox's more localized effect can be an advantage. Greater control over where the product stays helps reduce the risk of unintended muscle relaxation in adjacent areas. Our oculoplastic surgeon considers each patient's facial anatomy and treatment goals when selecting the best product and injection approach.
Cost Comparison
Understanding the cost differences between Botox and Dysport helps patients plan their treatment budget realistically. Dysport typically costs less per unit than Botox. However, because the two products are not dosed on a one-to-one basis, a lower per-unit price does not automatically mean a lower total treatment cost. The conversion ratio between the two products means that more units of Dysport are generally needed to achieve the same effect as a given number of Botox units.
When you account for the dosing conversion, the total cost of a Botox treatment and a Dysport treatment for the same area tends to be comparable. Some practices may price one slightly lower than the other, and promotional programs from each manufacturer can also influence out-of-pocket costs. We provide transparent pricing during your consultation so there are no surprises.
Cost is only one factor in choosing between Botox and Dysport. The skill and training of the injector, the appropriateness of the product for your anatomy, and the consistency of your results over time all contribute to the overall value of treatment. Combining neuromodulators with complementary approaches like microneedling for under-eye concerns or dermal fillers can also enhance your overall rejuvenation results.
Frequently Asked Questions
Both Botox and Dysport typically last three to four months, though individual results vary based on factors like metabolism, muscle strength, and the area treated. Some patients report that one product lasts slightly longer for them personally, which is why we sometimes recommend trying both over successive treatments to determine which works best for you.
Both products have strong safety profiles when injected by experienced providers. The periorbital region requires precise placement to avoid side effects like temporary eyelid heaviness, which is why having your treatment performed by a fellowship-trained oculoplastic surgeon is particularly important for injections near the eyes.
Yes, switching between the two products is safe and relatively common. Some patients alternate based on availability, promotional pricing, or personal preference after comparing their results with each product. We recommend waiting until your current treatment has fully worn off before switching so we can accurately assess how each product performs for you.
Both products effectively treat crow's feet, the fine lines that radiate from the outer corners of the eyes. Botox has a specific FDA approval for crow's feet, and its more localized diffusion can offer precise control in this delicate area. Dysport can also produce excellent results for crow's feet, particularly when a softer, more diffused effect is desired across the lateral eye area.
No, the two products are not interchangeable unit for unit. The general conversion ratio is approximately 2.5 to 3 units of Dysport for every 1 unit of Botox, though the exact ratio may vary slightly based on the treatment area and your individual response. This dosing difference is why comparing prices per unit alone can be misleading.
What our Patients say
Reviews
(3,408)